The Biobank functions as an open resource for clinical and biomedical research into ME/CFS, and in particular for research leading to the discovery of biomarkers for the diagnosis, prognosis, and stratification (sub-grouping) of cases, enabling a wide range of research studies now and in the future.
The UK ME/CFS Biobank currently stores samples from over 500 donors representing those with ME/CFS, MS (forming an MS control group) and Healthy Control donors. Over 28,000 aliquots of blood (collected over two time-points) have been processed and are currently held at the UCL/RFH Biobank in London.
“The Biobank is a much-needed resource, adding capacity and creating value for the research community and ultimately for people with M.E. Working collaboratively, we will increase efficiency and effectiveness which is critical if we are to achieve our vision of a world without M.E.”
Sonya Chowdhury, Chief Executive, Action for M.E.